This study was the first to systematically explore the interrelationships of CSF YKL-40 with AD biomarkers, neuroinflammation, cognitive function and brain structures, and elucidate the additive effects of neuroinflammation and hypertension on the associations between astrocyte reactivity and AD-related pathologies. The gene discussed is CHI3L1; the disease is Alzheimer disease.